Cargando…
ApoE4: an emerging therapeutic target for Alzheimer’s disease
BACKGROUND: The growing body of evidence indicating the heterogeneity of Alzheimer’s disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy, suggest that the development of a single magic cure suitable for all cases may not be possible. This calls for a shift in...
Autores principales: | Safieh, Mirna, Korczyn, Amos D., Michaelson, Daniel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425600/ https://www.ncbi.nlm.nih.gov/pubmed/30890171 http://dx.doi.org/10.1186/s12916-019-1299-4 |
Ejemplares similares
-
ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020) -
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023) -
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022) -
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
por: Liraz, Ori, et al.
Publicado: (2013) -
Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
por: Patel, Kavita, et al.
Publicado: (2021)